Global’s doctors participate in research exploring the safety and improvement of protocols using adipose-derived stem cells.
Miami Lakes, FL (PRUnderground) March 25th, 2019
..The purpose of the investigation is to evaluate the safety of and superior effectiveness of adipose-derived stem cells in functional improvement in patients with partial-thickness rotator cuff tears (PTRCTs)
..Up to 20 centers in the United States have will be invited to enroll in the study.
..Faculty members from the Global Stem Cells Group will be treating subjects enrolled in the study. Global was chosen to participate in this study due to its unique stature as a leader in regenerative medicine. The group is known for its comprehensive support of regenerative medicine solutions, starting with education, patient treatment and research and ending with the manufacturing and distribution of equipment for regenerative medicine practitioners.
ClinicalTrials.gov Identifier: NCT03752827 Studies a U.S. FDA-regulated Device Product: YES Principal Investigator: Jason Hurd, MD Sanford Orthopedics & Sports Medicine
There are over 5,000 registered clinical trials involving stem cells research on ClinicalTrials.gov, with new clinical trials in this field being offered every day.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.